Education
About Us
Working with TipRanks
Follow Us
CryoPort Inc (CYRX)
NASDAQ:CYRX
Earnings Data
Report Date
May 01, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.33Last Year’s EPS
-0.43Same Quarter Last Year
Moderate Buy
Based on 6 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 04, 2025
|% Change Since: 31.42%
|Next Earnings Date:May 01, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue performance, particularly in the Life Sciences Services business and commercial revenue growth. The company achieved significant improvements in gross margin and is optimistic about future revenue growth and profitability in 2025. However, macroeconomic challenges and concerns over the China market were noted as lowlights.Company Guidance
In Cryoport's Fourth Quarter and Full Year 2024 Earnings Conference Call, the company reported annual revenues of $228.4 million, aligning with expectations despite a challenging year for the life sciences sector. The Life Sciences Services segment, which accounted for 67% of total revenue, experienced double-digit growth in BioStorage and BioServices, with commercial cell and gene therapy support revenues increasing by 37% in Q4 and 20% for the full year. The company supported 701 clinical trials by year-end, a net increase of 26 from the previous year, with 81 trials in Phase 3. Cryoport's gross margin improved significantly, rising to 45.8% in Q4 from 40.6% the previous year, driven by cost management initiatives. Looking ahead to 2025, Cryoport provided revenue guidance between $240 million and $250 million, anticipating further capitalizing on cell and gene therapy industry growth and achieving positive adjusted EBITDA.Solid Revenue Performance
Cryoport concluded the year with total annual revenues of $228.4 million, in line with expectations. The Life Sciences Services business saw double-digit year-over-year growth in BioStorage and BioServices revenue for both the fourth quarter and full year.
Commercial Revenue Growth
Revenue growth for the support of commercial cell and gene therapies increased by 37% in the fourth quarter and 20% for the full year.
Expansion in Clinical Trials
Cryoport supported 701 clinical trials by the end of the year, a net increase of 26 clinical trials from the previous year, with a record number of commercial approvals increasing from 14 to 19.
Gross Margin Improvement
Gross margin rose to 45.8% in the fourth quarter compared to 40.6% in the same period last year due to cost management initiatives.
IntegriCell and New Product Launch
Opened IntegriCell cryopreservation solution facilities in Houston, Texas and Liege, Belgium. Introduced the Cryoport Express Cryogenic CXHV3 shipping system.
Positive Outlook for 2025
Providing full-year 2025 revenue guidance in the range of $240 million to $250 million, with an expectation of achieving positive adjusted EBITDA during 2025.
---
CYRX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CYRX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 04, 2025 | $5.06 | $6.61 | +30.63% |
| Nov 07, 2024 | $8.02 | $7.73 | -3.62% |
| Aug 06, 2024 | $7.79 | $7.77 | -0.26% |
| May 07, 2024 | $16.40 | $13.20 | -19.51% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does CryoPort Inc (CYRX) report earnings?
CryoPort Inc (CYRX) is schdueled to report earning on May 01, 2025, TBA Not Confirmed.
What is CryoPort Inc (CYRX) earnings time?
CryoPort Inc (CYRX) earnings time is at May 01, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CYRX EPS forecast?
CYRX EPS forecast for the fiscal quarter 2025 (Q1) is -0.33.
---